Potent and subtype-selective (>1000-fold) PPARgamma agonist [1]. Angiogenesis inhibitor [3]. Apoptosis inhibitor [4]. Anti-inflammatory [4]. Anti-hyperglycemic and anti-hyperlipidemic agent [1]. Antidiabetic. The glucose-lowering effect in rats is 100-fold more potent than that of troglitazone [2].
Puffer:
Solid
CAS Nummer:
[196808-24-9]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten